PRNCR1 and neoplasm: Specially, HULC has been discovered to be dysregulated in lung cancer in published literature [54]; Cheng et al. discovered that PRNCR1 could upregulate HEY2 by competitively bind miR-448 to promote tumor progression in non-small cell lung cancer [55].